ATOSSA THERAPEUTICS, INC. — Director's Dealing 2016

Apr 4, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ATOSSA GENETICS INC (ATOS)
CIK: 0001488039
Period of Report: 2016-04-01

Reporting Person: Remmel H. Lawrence (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-01	Common Stock	P	1500	$0.33	Acquired	10900	Direct

Footnotes

F1: The Reporting Person disclaims beneficial ownership of the 2,000 shares of common stock held by the Reporting Person's spouse and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.